PRF1 and endometrial cancer: Some scholars have reported that the expression of perforin in CD8+ tumor-infiltrating lymphocytes and peripheral blood T lymphocytes in patients with endometrial cancer increases the cytolytic capacity of CD8+ T cells [23].